84 related articles for article (PubMed ID: 12496979)
1. Transurethral prostatic tissue ablation via a single needle delivery system: initial experience with radio-frequency energy and ethanol.
Plante MK; Bunnell ML; Trotter SJ; Jackson TL; Esenler AC; Zvara P
Prostate Cancer Prostatic Dis; 2002; 5(3):183-8. PubMed ID: 12496979
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the transurethral ethanol ablation of the prostate (TEAP) for symptomatic benign prostatic hyperplasia (BPH): a European multi-center evaluation.
Grise P; Plante M; Palmer J; Martinez-Sagarra J; Hernandez C; Schettini M; Gonzalez-Martin M; Castiñeiras J; Ballanger P; Teillac P; Rolo F; Baena V; Erdmann J; Mirone V
Eur Urol; 2004 Oct; 46(4):496-501; discussion 501-2. PubMed ID: 15363567
[TBL] [Abstract][Full Text] [Related]
3. An open study on the efficacy and safety of transurethral needle ablation of the prostate in treating symptomatic benign prostatic hyperplasia: the University of Florida experience.
Kahn SA; Alphonse P; Tewari A; Narayan P
J Urol; 1998 Nov; 160(5):1695-700. PubMed ID: 9783934
[TBL] [Abstract][Full Text] [Related]
4. Transurethral needle ablation of the prostate: report of initial United States clinical trial.
Issa MM
J Urol; 1996 Aug; 156(2 Pt 1):413-9. PubMed ID: 8683692
[TBL] [Abstract][Full Text] [Related]
5. Phase I/II examination of transurethral ethanol ablation of the prostate for the treatment of symptomatic benign prostatic hyperplasia.
Plante MK; Marks LS; Anderson R; Amling C; Rukstalis D; Badlani G; Getlin L; Vang E
J Urol; 2007 Mar; 177(3):1030-5; discussion 1035. PubMed ID: 17296405
[TBL] [Abstract][Full Text] [Related]
6. Transurethral ethanol injection therapy of benign prostatic hyperplasia: four-year follow-up.
Sakr M; Eid A; Shoukry M; Fayed A
Int J Urol; 2009 Feb; 16(2):196-201. PubMed ID: 19054163
[TBL] [Abstract][Full Text] [Related]
7. The influence of baseline parameters on changes in international prostate symptom score with dutasteride, tamsulosin, and combination therapy among men with symptomatic benign prostatic hyperplasia and an enlarged prostate: 2-year data from the CombAT study.
Roehrborn CG; Siami P; Barkin J; Damião R; Becher E; Miñana B; Mirone V; Castro R; Wilson T; Montorsi F;
Eur Urol; 2009 Feb; 55(2):461-71. PubMed ID: 19013011
[TBL] [Abstract][Full Text] [Related]
8. Impact of prostate-specific antigen level and prostate volume as predictors of efficacy in photoselective vaporization prostatectomy: analysis and results of an ongoing prospective multicentre study at 3 years.
Te AE; Malloy TR; Stein BS; Ulchaker JC; Nseyo UO; Hai MA
BJU Int; 2006 Jun; 97(6):1229-33. PubMed ID: 16686717
[TBL] [Abstract][Full Text] [Related]
9. A prospective study of transperineal prostatic block for transurethral needle ablation for benign prostatic hyperplasia: the Emory University Experience.
Issa MM; Perez-Brayfield M; Petros JA; Anastasia K; Labadia AJ; Miller LE
J Urol; 1999 Nov; 162(5):1636-9. PubMed ID: 10524886
[TBL] [Abstract][Full Text] [Related]
10. Comparison of standard transurethral resection, transurethral vapour resection and holmium laser enucleation of the prostate for managing benign prostatic hyperplasia of >40 g.
Gupta N; Sivaramakrishna ; Kumar R; Dogra PN; Seth A
BJU Int; 2006 Jan; 97(1):85-9. PubMed ID: 16336334
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of benign hyperplasia of the prostate using thermal transurethral needle ablation (TUNA)].
Rodrígo Aliaga M; López Alcina E; Monserrat Monfort JJ; Pontones Moreno JL; Valls Blasco F; Boronat Tormo F; Jiménez Cruz JF
Actas Urol Esp; 1997; 21(7):649-54. PubMed ID: 9412206
[TBL] [Abstract][Full Text] [Related]
12. [A comparative study on different doses of cernilton for preventing the clinical progression of benign prostatic hyperplasia].
Xu J; Qian WQ; Song JD
Zhonghua Nan Ke Xue; 2008 Jun; 14(6):533-7. PubMed ID: 18649754
[TBL] [Abstract][Full Text] [Related]
13. Photoselective vaporization of the prostate in the treatment of benign prostatic hyperplasia.
Fu WJ; Hong BF; Yang Y; Cai W; Gao JP; Wang CY; Wang XX
Chin Med J (Engl); 2005 Oct; 118(19):1610-4. PubMed ID: 16232345
[TBL] [Abstract][Full Text] [Related]
14. Short term outcomes of high power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate.
Volkan T; Ihsan TA; Yilmaz O; Emin O; Selcuk S; Koray K; Bedi O
Eur Urol; 2005 Oct; 48(4):608-13. PubMed ID: 16135396
[TBL] [Abstract][Full Text] [Related]
15. Office based transurethral needle ablation of the prostate with analgesia and local anesthesia.
Leocádio DE; Frenkl TL; Stein BS
J Urol; 2007 Nov; 178(5):2052-4; discussion 2054. PubMed ID: 17869294
[TBL] [Abstract][Full Text] [Related]
16. Durability and cost-effectiveness of transurethral needle ablation of the prostate as an alternative to transurethral resection of the prostate when alpha-adrenergic antagonist therapy fails.
Rosario DJ; Phillips JT; Chapple CR
J Urol; 2007 Mar; 177(3):1047-51; discussion 1051. PubMed ID: 17296409
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of benign prostatic hyperplasia (BPH) by transurethral needle ablation (TUNA) and 36-month follow-up of the retreatment rate].
Martin X; Claude A; Colombel M; Sarramon JP; Ballanger P; Lobel B; Richard F; Saussine C; Cavillon C; Buzelin JM; Baron JC; Lambert D; Haillot O
Prog Urol; 2005 Sep; 15(4):674-80. PubMed ID: 16459684
[TBL] [Abstract][Full Text] [Related]
18. GreenLight laser vaporization of the prostate: single-center experience and long-term results after 500 procedures.
Ruszat R; Seitz M; Wyler SF; Abe C; Rieken M; Reich O; Gasser TC; Bachmann A
Eur Urol; 2008 Oct; 54(4):893-901. PubMed ID: 18486311
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up study to evaluate the efficacy and safety of the doxazosin gastrointestinal therapeutic system in patients with benign prostatic hyperplasia with or without concomitant hypertension.
Chung BH; Hong SJ
BJU Int; 2006 Jan; 97(1):90-5. PubMed ID: 16336335
[TBL] [Abstract][Full Text] [Related]
20. The long-term results of transurethral vaporization of the prostate using plasmakinetic energy.
Kaya C; Ilktac A; Gokmen E; Ozturk M; Karaman IM
BJU Int; 2007 Apr; 99(4):845-8. PubMed ID: 17378844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
